142 related articles for article (PubMed ID: 36374556)
41. Dihydrotanshinone I inhibits the growth of hepatoma cells by direct inhibition of Src.
Jiang XL; Deng B; Deng SH; Cai M; Ding WJ; Tan ZB; Chen RX; Xu YC; Xu HL; Zhang SW; Zhang SQ; Liu B; Zhang JZ
Phytomedicine; 2022 Jan; 95():153705. PubMed ID: 34538671
[TBL] [Abstract][Full Text] [Related]
42. Dauricine inhibits proliferation and promotes death of melanoma cells via inhibition of Src/STAT3 signaling.
Deng B; Jiang XL; Tan ZB; Cai M; Deng SH; Ding WJ; Xu YC; Wu YT; Zhang SW; Chen RX; Kan J; Zhang EX; Liu B; Zhang JZ
Phytother Res; 2021 Jul; 35(7):3836-3847. PubMed ID: 33792976
[TBL] [Abstract][Full Text] [Related]
43. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
Yu W; Xiao H; Lin J; Li C
J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
[TBL] [Abstract][Full Text] [Related]
44. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
[TBL] [Abstract][Full Text] [Related]
45. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
46. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
47. Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice.
Mackenzie GG; Huang L; Alston N; Ouyang N; Vrankova K; Mattheolabakis G; Constantinides PP; Rigas B
PLoS One; 2013; 8(5):e61532. PubMed ID: 23650499
[TBL] [Abstract][Full Text] [Related]
48. Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer.
Liu X; Guo X; Li H; Chen J; Qi X
Mol Med Rep; 2016 Jun; 13(6):4774-8. PubMed ID: 27082851
[TBL] [Abstract][Full Text] [Related]
49. Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.
Zhang T; Li J; Yin F; Lin B; Wang Z; Xu J; Wang H; Zuo D; Wang G; Hua Y; Cai Z
Oncogene; 2017 Nov; 36(47):6627-6639. PubMed ID: 28783167
[TBL] [Abstract][Full Text] [Related]
50. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.
Huang C; Yang G; Jiang T; Huang K; Cao J; Qiu Z
J Exp Clin Cancer Res; 2010 May; 29(1):51. PubMed ID: 20482858
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5.
Hu H; Zhang Q; Chen W; Wu T; Liu S; Li X; Luo B; Zhang T; Yan G; Lu H; Lu Z
Carcinogenesis; 2020 Jun; 41(4):502-514. PubMed ID: 31233116
[TBL] [Abstract][Full Text] [Related]
52. Screening of potent STAT3-SH2 domain inhibitors from JAK/STAT compound library through molecular dynamics simulation.
Manoharan S; Balakrishnan A; Hemamalini V; Perumal E
Mol Divers; 2023 Jun; 27(3):1297-1308. PubMed ID: 35831728
[TBL] [Abstract][Full Text] [Related]
53. Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.
Wörmann SM; Song L; Ai J; Diakopoulos KN; Kurkowski MU; Görgülü K; Ruess D; Campbell A; Doglioni C; Jodrell D; Neesse A; Demir IE; Karpathaki AP; Barenboim M; Hagemann T; Rose-John S; Sansom O; Schmid RM; Protti MP; Lesina M; Algül H
Gastroenterology; 2016 Jul; 151(1):180-193.e12. PubMed ID: 27003603
[TBL] [Abstract][Full Text] [Related]
54. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
Sen B; Saigal B; Parikh N; Gallick G; Johnson FM
Cancer Res; 2009 Mar; 69(5):1958-65. PubMed ID: 19223541
[TBL] [Abstract][Full Text] [Related]
55. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
56. Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening.
Liu LJ; Leung KH; Chan DS; Wang YT; Ma DL; Leung CH
Cell Death Dis; 2014 Jun; 5(6):e1293. PubMed ID: 24922077
[TBL] [Abstract][Full Text] [Related]
57. A natural xanthone suppresses lung cancer growth and metastasis by targeting STAT3 and FAK signaling pathways.
Zhao Y; Zhang X; Li Y; Li Y; Zhang H; Song Z; Xu J; Guo Y
Phytomedicine; 2022 Jul; 102():154118. PubMed ID: 35576741
[TBL] [Abstract][Full Text] [Related]
58. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
Huang W; Liu Y; Wang J; Yuan X; Jin HW; Zhang LR; Zhang JT; Liu ZM; Cui JR
Eur J Med Chem; 2018 Sep; 157():887-897. PubMed ID: 30145375
[TBL] [Abstract][Full Text] [Related]
59. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
Wu X; Cao Y; Xiao H; Li C; Lin J
Mol Cancer Ther; 2016 Nov; 15(11):2609-2619. PubMed ID: 27535971
[TBL] [Abstract][Full Text] [Related]
60. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.
Tang SN; Fu J; Shankar S; Srivastava RK
PLoS One; 2012; 7(2):e31067. PubMed ID: 22348037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
